Form 8-K - Current report:
SEC Accession No. 0001193125-20-310022
Filing Date
2020-12-04
Accepted
2020-12-04 07:31:28
Documents
1
Period of Report
2020-12-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d131020d8k.htm 8-K 15609
  Complete submission text file 0001193125-20-310022.txt   16796
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 201368723
SIC: 2834 Pharmaceutical Preparations